F2R and pneumonitis: Identification of these cytokines/chemokines by this study provides additional opportunities to examine mechanisms of bleomycin/thrombin/PAR1-induced lung injury/inflammation, and identifies potential therapeutic targets to ameliorate pneumonitis in bleomycin-treated patients.